title: [Study of the effect of converting enzyme inhibitors on microalbuminuria in diabetics].
abstract: The authors report the results of a randomised trial using a converting enzyme inhibitor in 40 microalbuminuric diabetic subjects during 18 months. In the treated group, we observed a reduction of albuminuria from 57.4 mg/24 hours to 35.4 mg/24 hours at the end of the follow up, in contrast with a non significant progression in the group who didn't receive this medication. No significant modification in the clinical and biological parameters was observed during the follow up.
authors: Service d'Endocrinologie, Diabétologie-Hôpital La Rabta, Tunis.
authors: B
authors: B
authors: Ben Rhaiem
authors: S
authors: S
authors: Ben Brahim
authors: M
authors: M
authors: Fekih
authors: B
authors: B
authors: Ftouhi
authors: F
authors: F
authors: Harzallah
authors: F
authors: F
authors: Kanoun
authors: A
authors: A
authors: Mekaouar
authors: A
authors: A
authors: M'bazaa
authors: F
authors: F
authors: Ben khalifa
mesh_terms: D000328:Adult; D000368:Aged; D000419:Albuminuria / Q000188:drug therapy* / Q000209:etiology; D048909:Diabetes Complications; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D004791:Enzyme Inhibitors